Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.54 USD
+0.04 (7.64%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.51 -0.03 (-5.20%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Earnings News For VIRX
-
Sunesis: Q1 Earnings Snapshot
-
Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Sunesis: Q4 Earnings Snapshot
-
Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Sunesis: Q3 Earnings Snapshot
-
Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Sunesis: Q2 Earnings Snapshot
-
Viracta Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Sunesis: Q1 Earnings Snapshot
-
Viracta Therapeutics Reports First Quarter 2023 Financial Results and Provides Clinical Program Updates
-
Sunesis: Q4 Earnings Snapshot
-
Viracta Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
-
Sunesis: Q3 Earnings Snapshot
-
Viracta Therapeutics Reports Third Quarter 2022 Financial Results and Provides Updates on Clinical Programs
-
Viracta Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates